Retrospective analysis of adverse events with spironolactone in females reported to the United States Food and Drug Administration

Ítems similars

• Retrospective analysis of dermatologic adverse events associated with hydroxychloroquine reported to the US Food and Drug Administration
  per: Lipner, Shari R., et al.
  Publicat: (2020)
• Retrospective analysis of smell and taste disturbances associated with dermatologic medications reported to the United States Food and Drug Administration and relevance to COVID-19 infections
  per: Wang, Yu, et al.
  Publicat: (2020)
• Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
  per: Toki, Tadashi, et al.
  Publicat: (2018)
• Assessment of the real-world safety profile of vedolizumab using the United States Food and Drug Administration adverse event reporting system
  per: Cross, Raymond K., et al.
  Publicat: (2019)
• Cosmetics and Cancer: Adverse Event Reports Submitted to the Food and Drug Administration
  per: Jacob, Saya L, et al.
  Publicat: (2018)